In an earlier retrospective population‐based cohort study of 535 women with endometrial cancer who received radiotherapy and/or chemotherapy, MMR deficiency was associated with favorable progression‐free survival and overall survival, but on multivariable analysis, the effect of MMR protein status was no longer significant.22 The gene discussed is MRC1; the disease is endometrial cancer.